About
Contact & Profiles
A5080564769
Research Areas
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Cancer Genomics and Diagnostics
- Dermatological and COVID-19 studies
- Metastasis and carcinoma case studies
- Lung Cancer Diagnosis and Treatment
- COVID-19 and healthcare impacts
- Genetic factors in colorectal cancer
- Colorectal Cancer Treatments and Studies
- COVID-19 Clinical Research Studies
- Soft tissue tumor case studies
- Occupational and environmental lung diseases
- Tissue Engineering and Regenerative Medicine
- Oral and Maxillofacial Pathology
- Colorectal and Anal Carcinomas
- IgG4-Related and Inflammatory Diseases
- Pleural and Pulmonary Diseases
- Colorectal Cancer Surgical Treatments
Ospedale "Santa Maria delle Croci" di Ravenna
2021-2022
Azienda Unità Sanitaria Locale Della Romagna
2020-2021
10.1016/j.humpath.2022.02.005
article
EN
Human Pathology
2022-02-15
3607 Background: The combination of capecitabine plus long course radiotherapy (RT) is the standard preoperative therapy in cT3-4 cN+ rectal cancer. Pathologic Complete remission (pCR) can be considered as surrogate end point efficacy treatment terms disease free survival (DFS). Preclinical data points heavily toward a strong synergy between RT and immune treatments. Methods: This prospective phase II, open label, single arm, multi-centre study, conducted with support from AstraZeneca,...
10.1200/jco.2021.39.15_suppl.3607
article
EN
Journal of Clinical Oncology
2021-05-20
Coming Soon ...